Cargando…

Machine learning algorithm as a prognostic tool for Epstein-Barr virus reactivation after haploidentical hematopoietic stem cell transplantation

Epstein-Barr virus (EBV) reactivation is one of the most important infections after hematopoietic stem cell transplantation (HSCT) using haplo-identical related donors (HID). We aimed to establish a comprehensive model with machine learning, which could predict EBV reactivation after HID HSCT with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Shuang, Hong, Hao-Yang, Dong, Xin-Yu, Xu, Lan-Ping, Zhang, Xiao-Hui, Wang, Yu, Yan, Chen-Hua, Chen, Huan, Chen, Yu-Hong, Han, Wei, Wang, Feng-Rong, Wang, Jing-Zhi, Liu, Kai-Yan, Shen, Meng-Zhu, Huang, Xiao-Jun, Hong, Shen-Da, Mo, Xiao-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891443/ https://www.ncbi.nlm.nih.gov/pubmed/36742189 http://dx.doi.org/10.1097/BS9.0000000000000143

Ejemplares similares

P573: NOVEL PROGNOSTIC MODEL FOR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Wen, Qi, et al.
Publicado: (2023)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia
por: Wang, Jing-Zhi, et al.
Publicado: (2021)

Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
por: Zhou, Jing-Rui, et al.
Publicado: (2021)

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder
por: Braun, Adam, et al.
Publicado: (2023)

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
por: Chang, Ying-Jun, et al.
Publicado: (2020)

Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
por: Xu, Lan-Ping, et al.
Publicado: (2019)

Epstein-Barr Virus Encephalitis and Disseminated Adenovirus Infection after Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for a Patient with Ph-Like Acute Lymphoblastic Leukemia
por: Zhou, Xiao, et al.
Publicado: (2022)

Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidates
por: Cao, Le-Qing, et al.
Publicado: (2020)

Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial
por: Wang, Yu, et al.
Publicado: (2022)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014)

Cardiovascular involvement in Epstein–Barr virus infection
por: Chen, Xinying, et al.
Publicado: (2023)

Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis
por: Chang, Ying-Jun, et al.
Publicado: (2017)

Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
por: Wu, Chung-Chun, et al.
Publicado: (2017)

Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study
por: Sun, Yu-Qian, et al.
Publicado: (2021)

Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy
por: Zhu, Peng, et al.
Publicado: (2013)

Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroids
por: Mo, Xiao-Dong, et al.
Publicado: (2018)

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
por: Fan, Shuang, et al.
Publicado: (2022)

Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation
por: Liu, Jiangying, et al.
Publicado: (2015)

Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis
por: Fei, Qian, et al.
Publicado: (2018)

Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia
por: Liang, Jin-Hua, et al.
Publicado: (2015)

Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
por: Li, Shan-shan, et al.
Publicado: (2022)

Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas
por: Zhang, Yi-wang, et al.
Publicado: (2014)

The Epstein Barr virus circRNAome
por: Ungerleider, Nathan, et al.
Publicado: (2018)

Urgency and necessity of Epstein-Barr virus prophylactic vaccines
por: Zhong, Ling, et al.
Publicado: (2022)

CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020)

Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies
por: Shen, Meng-Zhu, et al.
Publicado: (2022)

Graft Failure in Patients With Hematological Malignancies: A Successful Salvage With a Second Transplantation From a Different Haploidentical Donor
por: Sun, Yu-Qian, et al.
Publicado: (2021)

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
por: Huang, Junbin, et al.
Publicado: (2023)

Stress-Induced Epstein-Barr Virus Reactivation
por: Sausen, Daniel G., et al.
Publicado: (2021)

Pancreatitis Combined with Epstein–Barr Virus-induced Infectious Mononucleosis
por: Zhu, Zhen, et al.
Publicado: (2017)

Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
por: Yu, Xing-Xing, et al.
Publicado: (2022)

Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients
por: Wei, Hong-Tao, et al.
Publicado: (2023)

Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation
por: Jin, Fengyan, et al.
Publicado: (2016)

Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma
por: Liao, Ying, et al.
Publicado: (2023)

The Dietary Flavonol Kaempferol Inhibits Epstein–Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells
por: Wu, Chung-Chun, et al.
Publicado: (2022)

Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient
por: Hu, Juan, et al.
Publicado: (2023)

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma
por: Zhang, Hui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mf9mkcltp6bn8h107oskju9noj